- Home
- TCBS vs GRCE Comparison
TCBS vs GRCE Comparison
Compare TCBS & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- GRCE
- Stock Information
- Founded
- TCBS 1934
- GRCE 2002
- Country
- TCBS United States
- GRCE United States
- Employees
- TCBS N/A
- GRCE N/A
- Industry
- TCBS Banks
- GRCE
- Sector
- TCBS Finance
- GRCE
- Exchange
- TCBS Nasdaq
- GRCE NYSE
- Market Cap
- TCBS 44.9M
- GRCE 40.0M
- IPO Year
- TCBS N/A
- GRCE N/A
- Fundamental
- Price
- TCBS $15.75
- GRCE $2.77
- Analyst Decision
- TCBS
- GRCE Strong Buy
- Analyst Count
- TCBS 0
- GRCE 1
- Target Price
- TCBS N/A
- GRCE $12.00
- AVG Volume (30 Days)
- TCBS 3.5K
- GRCE 29.0K
- Earning Date
- TCBS 06-10-2025
- GRCE 06-10-2025
- Dividend Yield
- TCBS 1.02%
- GRCE N/A
- EPS Growth
- TCBS N/A
- GRCE N/A
- EPS
- TCBS 0.68
- GRCE N/A
- Revenue
- TCBS $14,488,000.00
- GRCE N/A
- Revenue This Year
- TCBS N/A
- GRCE N/A
- Revenue Next Year
- TCBS N/A
- GRCE N/A
- P/E Ratio
- TCBS $23.15
- GRCE N/A
- Revenue Growth
- TCBS 54.08
- GRCE N/A
- 52 Week Low
- TCBS $13.51
- GRCE $1.75
- 52 Week High
- TCBS $17.50
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- TCBS 54.51
- GRCE N/A
- Support Level
- TCBS $15.50
- GRCE N/A
- Resistance Level
- TCBS $15.58
- GRCE N/A
- Average True Range (ATR)
- TCBS 0.05
- GRCE 0.00
- MACD
- TCBS 0.03
- GRCE 0.00
- Stochastic Oscillator
- TCBS 62.50
- GRCE 0.00
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.